134 related articles for article (PubMed ID: 937370)
1. Low dose radioiodide thyroid ablation in postsurgical patients with thyroid cancer.
McCowen KD; Adler RA; Ghaed N; Verdon T; Hofeldt FD
Am J Med; 1976 Jul; 61(1):52-8. PubMed ID: 937370
[TBL] [Abstract][Full Text] [Related]
2. Feasibility of low doses of I-131 for thyroid ablation in postsurgical patients with thyroid carcinoma.
Siddiqui AR; Edmondson J; Wellman HN; Hamaker RC; Lingeman RE; Park HM; Johnston CC
Clin Nucl Med; 1981 Apr; 6(4):158-61. PubMed ID: 7214770
[TBL] [Abstract][Full Text] [Related]
3. Radioiodine dose for remnant ablation in differentiated thyroid carcinoma: a randomized clinical trial in 509 patients.
Bal CS; Kumar A; Pant GS
J Clin Endocrinol Metab; 2004 Apr; 89(4):1666-73. PubMed ID: 15070929
[TBL] [Abstract][Full Text] [Related]
4. Comparison of 800 and 3700 MBq iodine-131 for the postoperative ablation of thyroid remnant in patients with low-risk differentiated thyroid cancer.
Caglar M; Bozkurt FM; Akca CK; Vargol SE; Bayraktar M; Ugur O; Karaağaoğlu E
Nucl Med Commun; 2012 Mar; 33(3):268-74. PubMed ID: 22205241
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors in well-differentiated thyroid carcinoma in patients treated and followed in the same institution.
Cappelli C; Pirola I; Braga M; De Martino E; Morassi ML; Gandossi E; Mattanza C; Balzano R; Castellano M; Rosei EA
Ann Ital Chir; 2006; 77(2):107-13. PubMed ID: 17147082
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of I131 ablation therapy using different doses as determined by postoperative thyroid scan uptake in patients with differentiated thyroid cancer.
Zidan J; Hefer E; Iosilevski G; Drumea K; Stein ME; Kuten A; Israel O
Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1330-6. PubMed ID: 15275717
[TBL] [Abstract][Full Text] [Related]
7. Effect of postoperative 131I treatment on thyroglobulin measurements in the follow-up of patients with thyroid cancer.
Baskin HJ
Thyroid; 1994; 4(3):239-42. PubMed ID: 7833657
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of low-dose radioiodine ablation therapy in postsurgical thyroid cancer patients.
Ramanna L; Waxman AD; Brachman MB; Tanasescu DE; Sensel N; Braunstein GD
Clin Nucl Med; 1985 Nov; 10(11):791-5. PubMed ID: 4075672
[TBL] [Abstract][Full Text] [Related]
9. [Patients treated for differentiated thyroid cancer with negative 131I whole-body scans and elevated thyroglobulin levels: a possible course].
Gutiérrez Cardo AL; Rodríguez Rodríguez JR; Borrego Dorado I; Navarro González E; Tirado Hospital JL; Vázquez Albertino R
Rev Esp Med Nucl; 2007; 26(3):138-45. PubMed ID: 17524307
[TBL] [Abstract][Full Text] [Related]
10. [Recurrences and metastases in differentiated thyroid cancer].
Petkov R
Khirurgiia (Sofiia); 1995; 48(2):8-10. PubMed ID: 8531449
[TBL] [Abstract][Full Text] [Related]
11. A randomized clinical trial comparing 50mCi and 100mCi of iodine-131 for ablation of differentiated thyroid cancers.
Zaman Mu; Toor R; Kamal S; Maqbool M; Habib S; Niaz K
J Pak Med Assoc; 2006 Aug; 56(8):353-6. PubMed ID: 16967785
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of low-dose iodine-131 ablation of post-operative thyroid remnants: a study of 69 cases.
Leung SF; Law MW; Ho SK
Br J Radiol; 1992 Oct; 65(778):905-9. PubMed ID: 1422665
[TBL] [Abstract][Full Text] [Related]
13. [Long-term course in differentiated thyroid gland carcinoma].
Rösler H; Birrer A; Lüscher D; Kinser J
Schweiz Med Wochenschr; 1992 Nov; 122(48):1843-57. PubMed ID: 1462145
[TBL] [Abstract][Full Text] [Related]
14. Assessment of the efficacy of iodine-131 for thyroid ablation.
Comtois R; Thériault C; Del Vecchio P
J Nucl Med; 1993 Nov; 34(11):1927-30. PubMed ID: 8229236
[TBL] [Abstract][Full Text] [Related]
15. Selective postoperative radioactive iodine treatment of thyroid carcinoma.
McHenry C; Jarosz H; Davis M; Barbato AL; Lawrence AM; Paloyan E
Surgery; 1989 Dec; 106(6):956-8; discussion 958-9. PubMed ID: 2588122
[TBL] [Abstract][Full Text] [Related]
16. The use of radioactive iodine in thyroid carcinoma.
Goolden AW
Eur J Cancer Clin Oncol; 1988 Feb; 24(2):339-43. PubMed ID: 3281849
[TBL] [Abstract][Full Text] [Related]
17. Radioactive iodine lobe ablation as an alternative to completion thyroidectomy for follicular carcinoma of the thyroid.
Randolph GW; Daniels GH
Thyroid; 2002 Nov; 12(11):989-96. PubMed ID: 12490076
[TBL] [Abstract][Full Text] [Related]
18. Is it still worthwhile to treat bone metastases from differentiated thyroid carcinoma with radioactive iodine?
Proye CA; Dromer DH; Carnaille BM; Gontier AJ; Goropoulos A; Carpentier P; Lefebvre J; Decoulx M; Wemeau JL; Fossati P
World J Surg; 1992; 16(4):640-5; discussion 645-6. PubMed ID: 1384244
[TBL] [Abstract][Full Text] [Related]
19. Thyroid ablation with 1.1 GBq (30 mCi) iodine-131 in patients with papillary thyroid carcinoma at intermediate risk for recurrence.
Rosário PW; Calsolari MR
Thyroid; 2014 May; 24(5):826-31. PubMed ID: 24283207
[TBL] [Abstract][Full Text] [Related]
20. Outcome after treatment of high-risk papillary and non-Hürthle-cell follicular thyroid carcinoma.
Taylor T; Specker B; Robbins J; Sperling M; Ho M; Ain K; Bigos ST; Brierley J; Cooper D; Haugen B; Hay I; Hertzberg V; Klein I; Klein H; Ladenson P; Nishiyama R; Ross D; Sherman S; Maxon HR
Ann Intern Med; 1998 Oct; 129(8):622-7. PubMed ID: 9786809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
